Modern Dental Marketing at 2011 AACD Meeting in Boston

Boston, MA (PRWEB) May 04, 2011

The American Academy of Cosmetic Dentistry (AACD) is hosting their 27th Annual Scientific Session in Boston, MA from May 18-21, 2011. Specializing in search engine marketing and website design for cosmetic dentists, CEO Keith Humes says his Rosemont Media team can be found in booth 2228 in the Boston Convention and Exhibition Center throughout the entire conference. Whether attendees have questions regarding dental Facebook marketing, online advertising, or the latest innovations in website design, Humes says he looks forward to the AACD conference and the chance to interact with leaders of the cosmetic dentistry industry.

The focus of the 27th Annual AACD Session is the Rise of Collaboration and the importance of teamwork in the modern cosmetic dentistry practice. As the modern incarnation of the traditional ad agency, Humes says Rosemont Media positions itself as an extension of each client’s cosmetic dentistry practice. He adds that this year’s focus on collaboration is especially poignant as the popularity and community-driven impact of social media sites such as Facebook and Twitter continues to improve search engine marketing for cosmetic dentists.

As Humes and the entire Rosemont Media team prepare for the AACD Boston 2011 meeting, he stresses the importance of quality engagement through a diverse social media marketing campaign. “We help our clients focus on the essential components of internet marketing, beginning with how to develop a social media strategy, how to promote your practice and convert fans into patients, and how to measure the ROI of social media.” However, Humes says the success of social media ultimately relies heavily on each practice's willingness to reach out to current and potential patients through their social networks.

About Rosemont Media

Rosemont Media is the modern ad agency, operating at the nexus of traditional advertising campaigns and innovative search engine marketing strategies. As a 13-year SEO veteran, CEO Keith Humes continues to develop his innovative approach to cosmetic dentistry marketing and website design. To provide their clients with the ultimate competitive advantage, Rosemont Media works under strict market exclusivity terms, meaning they focus on one practice per local market.

Rosemont Media is located at 1010 Turquoise St. Ste. 201 San Diego, CA 92019. The SEM firm can be reached at (800) 491-8623, or found online at http://www.rosemontmedia.com, the Rosemont Media Facebook page, or the @rosemontmedia Twitter handle.

###

http://seeebook.com/

Misonix Exhibits at Annual APTA-CSM Meeting

Posted on: Monday, 2 May 2011, 15:02 CDT

FARMINGDALE, N.Y., May 2, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications has announced their attendance at the American Physical Therapy Association's (APTA) Combined Sections Meeting (CSM), which was held in New Orleans, LA, February 10-12, 2011. Misonix exhibited and presented its SonicOneR Ultrasonic Wound Cleansing and Debridement System to many of the more than 5,000 clinicians in attendance. In addition, the SonicOne was demonstrated during the Wound Debridement Skills Pre-Conference Course on February 9, 2011.

As part of the educational program a clinical poster was presented on February 12, 2011 that focused on the clinical effectiveness of the SonicOne when used to treat chronic wounds. Frank Aviles, PT, CWS, WCC, FAACWS, Director of Therapy for a leading long term acute care facility in Natchitoches, LA, was the author and presenter of the material. Three separate clinical cases were followed from patient admission to wound closure. In two of the cases, the initial clinical plan included amputation. However, using a SonicOne debridement protocol to remove non-viable tissue allowed the establishment of a well-granulated wound bed, which contributed to healing, and resulted in both patients retaining their limbs and functional mobility.

The SonicOne is an innovative ultrasonic wound care system that offers tissue specific debridement and cleansing for effective removal of devitalized tissue and fibrin deposits while sparing viable cellular structures. The SonicOne establishes a new standard in advanced wound care and ensures progress towards patient healing.

"Misonix is pleased to demonstrate its commitment to the rapidly expanding wound care market by supporting important educational programs like APTA-CSM," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. "Our wound care product platform, we believe, makes an important contribution to improving patient outcomes and we are pleased when data is presented by clinical experts that support our investment in wound care research and development."

About APTA: APTA, which has a specialty section for advanced wound care, is a national professional organization representing more than 71,000 members. Its goal is to foster advancements in physical therapy practice, research, and education. The CSM is a unique conference that focuses on programming designed by all 18 of APTA's specialty sections.

About Misonix: Misonix, Inc. (NASDAQ: MSON) designs, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually, Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

Investor Relations Contact:
Kevin McGrath/Cameron Associates, Inc.
212-245-4577
Kevin@cameronassoc.com

SOURCE Misonix, Inc.

Source: PR Newswire

More News in this Category

View the original article here